Literature DB >> 1793583

Conditions affecting direct gene transfer into rodent muscle in vivo.

J A Wolff1, P Williams, G Acsadi, S Jiao, A Jani, W Chong.   

Abstract

This report extends our previous findings that mouse muscle cells in situ can take up naked DNA injected intramuscularly in vivo. Various conditions such as needle type, speed of injection, volume of injection fluid, tonicity of injection fluid, type of solute, type of muscle, physiologic condition of the muscle and age of the animals were appraised for their effect on the levels of luciferase activity expressed from the pRSVL plasmid. Specific conditions such as the use of normal saline as an injection fluid increased the efficiency of expression. The implantation of DNA pellets was an effective way to deliver DNA to muscle, especially for smaller muscle groups. Also, newborn and adult rat muscles expressed plasmid DNA delivered intramuscularly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1793583

Source DB:  PubMed          Journal:  Biotechniques        ISSN: 0736-6205            Impact factor:   1.993


  31 in total

Review 1.  Nucleic acid vaccines: tasks and tactics.

Authors:  B S McKenzie; A J Corbett; J L Brady; C M Dyer; R A Strugnell; S J Kent; D R Kramer; J S Boyle; A M Lew
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 2.  Nanotechnology approaches for gene transfer.

Authors:  Karin E Lundin; Oscar E Simonson; Pedro M D Moreno; Eman M Zaghloul; Iulian I Oprea; Mathias G Svahn; C I Edvard Smith
Journal:  Genetica       Date:  2009-06-02       Impact factor: 1.082

Review 3.  Physical methods of nucleic acid transfer: general concepts and applications.

Authors:  Julien Villemejane; Lluis M Mir
Journal:  Br J Pharmacol       Date:  2009-01-21       Impact factor: 8.739

4.  DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotoxicity.

Authors:  J S Boyle; A Silva; J L Brady; A M Lew
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

Review 5.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

6.  Cholera toxin B subunit acts as a potent systemic adjuvant for HIV-1 DNA vaccination intramuscularly in mice.

Authors:  Jue Hou; Ying Liu; Jenny Hsi; Hongzhi Wang; Ran Tao; Yiming Shao
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

7.  Induction of systemic and mucosal immune responses to human immunodeficiency virus type 1 by a DNA vaccine formulated with QS-21 saponin adjuvant via intramuscular and intranasal routes.

Authors:  S Sasaki; K Sumino; K Hamajima; J Fukushima; N Ishii; S Kawamoto; H Mohri; C R Kensil; K Okuda
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

8.  Stability and functional effectiveness of phosphorothioate modified duplex DNA and synthetic 'mini-genes'.

Authors:  S A Ciafrè; M Rinaldi; P Gasparini; D Seripa; L Bisceglia; L Zelante; M G Farace; V M Fazio
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

9.  Molecular enhancement of porcine cardiac chronotropy.

Authors:  J M Edelberg; D T Huang; M E Josephson; R D Rosenberg
Journal:  Heart       Date:  2001-11       Impact factor: 5.994

10.  Identification and characterization of a 47 base pair activity-dependent enhancer of the rat nicotinic acetylcholine receptor delta-subunit promoter.

Authors:  W Walke; G Xiao; D Goldman
Journal:  J Neurosci       Date:  1996-06-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.